Actuate Therapeutics ACTU Income Statement (2023-2026)

NASDAQ ACTU
$0.70 +0.01 (+2.03%)
As of: Sep 30, 2026 · 9:53 AM EDT
Reported Financials

Actuate Therapeutics Quarterly Income Statement

Periods 12 quarters
Latest Jun 2026

Actuate Therapeutics reported net income of -$4.87M for the quarter ended Jun 2026. This income statement covers 12 quarters of results from Jun 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.) 1.69M1.69M1.69M1.69M1.57M10.77M8.37M19.53M20.47M23.24M23.25M24.01M
Operating items
Research & DevelopmentR&D 4.78M5.76M6.65M6.86M4.37M3.76M3.69M3.22M2.76M2.18M2.13M2.07M
Selling, General & AdministrativeSG&A 0.81M0.71M0.97M0.91M1.06M1.64M2.87M3.15M3.20M3.29M2.56M2.84M
Operating ExpensesOpex 5.58M6.48M7.62M7.77M5.44M5.39M6.56M6.37M5.97M5.47M4.69M4.91M
Operating IncomeOp. Inc -5.58M-6.48M-7.62M-7.77M-5.44M-5.39M-6.56M-6.37M-5.97M-5.47M-4.69M-4.91M
EBIT -5.58M-6.48M-7.62M-7.77M-5.44M-5.39M-6.56M-6.37M-5.97M-5.47M-4.69M-4.91M
Non-operating items
Non Operating Interest Expenses 0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M
Interest & Investment IncomeInt & Inv Inc 0.13M0.06M0.01M0.01M0.08M0.12M0.05M0.02M0.07M0.14M0.05M
Other Non Operating IncomeOther Non Op Inc. 0.05M-0.02M0.05M0.03M0.24M-0.19M
Non Operating IncomeNon Op. Inc. 0.06M0.14M0.00M-0.52M-1.14M-0.58M0.11M0.05M0.02M0.06M0.13M0.04M
Net income details
EBT -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Profit After TaxPAT -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Income from Continuing OperationsIncome (Continuing) -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Consolidated Net IncomeConsol Net Inc. -5.59M-6.35M-7.56M-7.76M-5.43M-5.32M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Income towards Parent CompanyParent Net Inc -5.52M-6.34M-7.61M-8.30M-6.57M-5.97M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Net Income towards Common StockholdersNet Income -5.52M-6.34M-7.61M-8.30M-6.57M-5.97M-6.45M-6.32M-5.95M-5.41M-4.55M-4.87M
Additional items
EPS (Basic) -3.88-4.31-5.30-5.40-4.20-0.55-0.77-0.32-0.30-0.25-0.22-0.20
EPS (Diluted) -3.88-4.31-5.30-5.40-4.20-0.55-0.77-0.32-0.30-0.25-0.22-0.20
Shares Outstanding 1.42M1.47M1.43M1.54M1.57M10.77M8.37M19.50M19.65M21.39M21.02M23.87M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 1.42M1.47M1.43M1.54M1.57M10.77M8.37M19.50M19.65M21.39M21.02M23.87M
Interest ExpensesInt Expense 0.01M0.01M0.01M0.01M0.01M0.00M0.01M0.01M0.01M0.01M0.01M0.01M

Actuate Therapeutics Income Statement API

Pull Actuate Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=ACTU&statement=IS&frequency=Quarter&period=all&api_key=YOUR_API_KEY